A Multiple Ascending Dose Study of Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers

NCT04007263 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke, Ischemic
Pain, Postoperative
Substance Abuse
Subarachnoid Hemorrhage

Interventions

DRUG: Placebo
DRUG: NP10679

Sponsor

Neurop Inc.

Collaborators

[object Object]
[object Object]